The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance - Jbilo, O; Ravinet-Trillou, C; Arnone, M; Buisson, I; Bribes, E; Peleraux, A; Penarier, G; Soubrie, P; Le Fur, G; Galiegue, S; Casellas, P (FASEB J, 2005)